By G HossainPosted on September 21, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Deals for Chinese radiopharmaceutical assets have been rare to date and there is a limited pool of potential Western buyers available, Sleuth said. Western licensing deals for Chinese radioligand therapies to jump in 2027, Sleuth forecasts Post navigation Novo’s plan to hit $23B in revenue by 2035 leaves investors wantingThe 3-phase roadmap every accounting firm needs for AI
